Cellyan Biotechnology Co., Ltd Adjustments For Depreciation And Amortisation Expense
Cellyan Biotechnology Co., Ltd (HKPD) reported Adjustments For Depreciation And Amortisation Expense of $47.39 thousand for the 6-month period ending 2025-09-30, per its 6-K filed 2026-03-18.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense · last filed 2026-03-18
| Period end | Adjustments For Depreciation And Amortisation Expense 6 month | Adjustments For Depreciation And Amortisation Expense 12 month |
|---|---|---|
| 2025-09-30 | $47.39K 6-K · filed 2026-03-18 | |
| 2025-03-31 | $75.77K 20-F · filed 2025-08-14 | |
| 2024-09-30 | $34.05K 6-K · filed 2026-03-18 | |
| 2024-03-31 | $64.24K 20-F · filed 2025-08-14 | |
| 2023-03-31 | $73.99K 20-F · filed 2025-08-14 |